CORPORATES HEALTH Indoco Remedies receives USFDA final approval for Brivaracetam Oral Solution 10 mg/mL Feb 24, 2026
QUARTERLY RESULTS Indoco Remedies Q3 Results: Revenue rises 8.5% YoY to Rs 445.4 crore, net loss at Rs 29.8 crore Feb 3, 2026
CORPORATES Indoco Remedies’ Patalganga API facility clears USFDA inspection with zero observations Sep 19, 2025